Align Technology, Inc. $ALGN Stock: Colonial Trust Co SC Increases Stake

Colonial Trust Co SC boosted its holdings in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 254,205.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 45,775 shares of the medical equipment provider’s stock after buying an additional 45,757 shares during the quarter. Colonial Trust Co SC’s holdings in Align Technology were worth $6,057,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Align Technology in the second quarter worth about $745,370,000. Assenagon Asset Management S.A. grew its holdings in shares of Align Technology by 638.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock valued at $629,469,000 after purchasing an additional 4,031,284 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its holdings in shares of Align Technology by 3,162.7% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after purchasing an additional 2,033,451 shares during the last quarter. Vontobel Holding Ltd. increased its position in Align Technology by 69,628.9% during the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock worth $183,335,000 after purchasing an additional 1,383,526 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Align Technology by 4.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider’s stock worth $180,796,000 after purchasing an additional 49,220 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

Align Technology stock opened at $163.96 on Thursday. The business has a 50 day moving average of $152.24 and a 200-day moving average of $168.57. Align Technology, Inc. has a 1 year low of $131.95 and a 1 year high of $200.43. The company has a market capitalization of $11.56 billion, a P/E ratio of 23.87, a P/E/G ratio of 2.12 and a beta of 1.74.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same quarter last year, the business earned $2.61 EPS. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. Equities analysts anticipate that Align Technology, Inc. will post 9.21 EPS for the current year.

Analyst Ratings Changes

ALGN has been the subject of several research reports. Mizuho dropped their price objective on shares of Align Technology from $220.00 to $200.00 and set an “outperform” rating for the company in a research note on Thursday, October 22nd. Zacks Research raised shares of Align Technology from a “strong sell” rating to a “hold” rating in a research note on Friday, November 13th. Robert W. Baird downgraded shares of Align Technology from an “outperform” rating to a “neutral” rating and lowered their price target for the stock from $218.00 to $162.00 in a report on Thursday, October 15th. Raymond James Financial reiterated a “buy” rating on shares of Align Technology in a research note on Monday, October 5th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a report on Thursday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $193.08.

Get Our Latest Report on ALGN

Align Technology Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Further Reading

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.